a commercial-stage pharmaceutical company, which engages in the development and commercialization of therapies for the treatment of neurological disorders
Industry Biotechnology
A.I.dvisor indicates that over the last year, HRMY has been loosely correlated with GSGTF. These tickers have moved in lockstep 44% of the time. This A.I.-generated data suggests there is some statistical probability that if HRMY jumps, then GSGTF could also see price increases.
Ticker / NAME | Correlation To HRMY | 1D Price Change % | ||
---|---|---|---|---|
HRMY | 100% | -3.53% | ||
GSGTF - HRMY | 44% Loosely correlated | N/A | ||
SAGE - HRMY | 43% Loosely correlated | N/A | ||
ANAB - HRMY | 42% Loosely correlated | -3.49% | ||
GYRE - HRMY | 38% Loosely correlated | -9.56% | ||
CRSP - HRMY | 35% Loosely correlated | -1.85% | ||
More |
Ticker / NAME | Correlation To HRMY | 1D Price Change % |
---|---|---|
HRMY | 100% | -3.53% |
therapies theme (2 stocks) | 99% Closely correlated | -2.17% |
brain theme (2 stocks) | 96% Closely correlated | -3.01% |
pharmaceutical theme (3 stocks) | 92% Closely correlated | -2.21% |
treatment theme (56 stocks) | 41% Loosely correlated | -1.12% |